Tania Vrionis
CEO,
Ovarian Cancer Canada
Ovarian Cancer Canada redefines treatment landscape through research
Women’s healthcare is underfunded and overlooked until it’s often too late. In the case of ovarian cancer, patients are receiving their diagnoses at such an advanced stage that current available treatments aren’t effective long-term. This truth is the result of historic and systemic problems. Decades of underfunding ovarian cancer research means we do not have enough information to improve patient outcomes. If we’re going to make up for lost time and address these problems, we need to be bold and unapologetic in our pursuit of change.
At Ovarian Cancer Canada, we are transforming into the research engine for Canadian women. In the past five years, we redefined the landscape of ovarian cancer treatment through strategic partnerships and our $16 million research investment. From ensuring the disease is accurately tested in laboratories to identifying new treatments for those who have run out of options, we have introduced a new era in the work to change patient outcomes, for good.
After 60 years without meaningful change, now is the time demand action.
We are the only national health charity in Canada solely focused on ovarian cancer; no one else is in the position we are to be the changemakers women need us to be. Women facing this disease deserve our attention. They deserve our focus on saving their lives. Towards this goal, we are relentless.
Learn more at ovariancanada.org.
